Alnylam Pharma (ALNY) – Trading Halts
-
Alnylam Pharma (ALNY) Announces Receipt of CRL from U.S. FDA for sNDA for Patisiran for the Treatment of the Cardiomyopathy of ATTR Amyloidosis
-
Alnylam Pharma (ALNY) Halted, News Pending
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ALNY Stock Lookup